DIN 02460548 — KEVZARA 200 MG
KEVZARA is a solution of Sarilumab marketed by SANOFI-AVENTIS CANADA INC. The full Sarilumab monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02460548
- Brand name
- KEVZARA
- Active ingredient
- Sarilumab
- Strength
- 200 MG
- Dosage form
- SOLUTION
- Route
- SUBCUTANEOUS
- Manufacturer
- SANOFI-AVENTIS CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Interleukin-6 (IL-6) receptor antagonist (monoclonal antibody)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Sarilumab products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02472961 | KEVZARA | 150 MG | SOLUTION | SANOFI-AVENTIS CANADA INC | MARKETED |
| 02472988 | KEVZARA | 200 MG | SOLUTION | SANOFI-AVENTIS CANADA INC | MARKETED |